Jul. 22 at 8:06 PM
$TDOC -
$TDOC Tuesday 29th er, heavily shorted.
Lost flyer, coiled spring. 2.5Bil Rev's and 1.5Bil market cap.
$TDOC 2025 Projected Revenue:
$3.1–
$3.2 billion
Relevant Peer Group Revenue Multiples (2025):
Amwell (
$AMWL): 1.4x revenue
Hims & Hers (
$HIMS): 3.9x revenue
Doximity (
$DOCS): 16x revenue
Health Catalyst (
$HCAT): 3.6x revenue
AI/Telehealth Peer Median: 2–4x revenue
TDOC Valuation at Peer Revenue Multiples
Revenue Multiple Implied Enterprise Value Implied Share Price (Estimate)
2x
$6.2–
$6.4 billion
$37–
$39
3x
$9.3–
$9.6 billion
$55–
$58
4x
$12.4–
$12.8 billion
$74–
$78
16x (
$DOCS)
$49.6–
$51.2 billion
$300+
Current Market Cap of
$TDOC at 8.42 share: ~
$1.46 billion
Revenue-multiple-based re-rating (at peer medians 2x–4x): TDOC could be valued at 4–10x its current market cap if it achieves peer-average metrics.
Key Insights:
Metric Value/Percent
Short Interest 24.59 million shares
Short % of Float 14.10%–14.17%
Short Interest Ratio (Days) 3.9
Public Float 173.5 million shares
Institutional Ownership 76.8%
Short Interest:
Short Interest (shares): 24.59 million
Short Interest as % of Float: 14.10%–14.17%
Short Interest Ratio (Days to Cover): ~3.9
Trend: This is a 14% increase in short interest from the previous month.
TDOC maintains one of the highest short interest ratios in the digital health sector, with institutional investors holding the majority of shares. The short interest has increased notably over the past month, and the stock remains under close watch by both institutions and short sellers
Conclusion:
If Teladoc achieves operating performance or technology positioning consistent with leading AI-enabled and telehealth peers, simply applying the current peer group revenue multiples (2x–4x) suggests a share price potential of
$37–
$78+, representing a substantial upside from current levels.
